The importance of pretreatment testosterone and other prognostic variables in the response to androgen deprivation therapy
Soloway, M.S.
Progress in Clinical and Biological Research 350: 141-148
1990
ISSN/ISBN: 0361-7742 PMID: 2201040 Document Number: 359206
Document emailed within 1 workday
Related Documents
Koivisto, P.; Kononen, J.; Palmberg, C.; Tammela, T.; Hyytinen, E.; Isola, J.; Trapman, J.; Cleutjens, K.; Noordzij, A.; Visakorpi, T.; Kallioniemi, O.P. 1997: Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer Cancer Research 57(2): 314-319Reuter, V.E. 1990: Pathology of bladder cancer: assessment of prognostic variables and response to therapy Seminars in Oncology 17(5): 524-532
Rentsch, C.A.; Aebersold, D.M.; Merz, V.; Studer, U.E. 2005: Cancer of the prostate: importance of androgen deprivation and radiotherapy Revue Medicale Suisse 1(19): 1303-1306
Rees, J. 2015: Androgen deprivation therapy and cardiovascular risk Practitioner 259(1785): 5
Buyyounouski, M.K. 2010: Androgen deprivation therapy in high-risk prostate cancer Oncology 24(9): 806; 809
Arai, G.; Okada, H. 2016: Androgen deprivation therapy for prostate cancer: adverse effects and their management Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 3): 605-609
2006: Bisphosphonates effective in preventing bone complications associated with androgen deprivation therapy Journal of Supportive Oncology 4(2): 99-100
Ying, J.; Yao, D.-H.; Ren, X.-M. 2003: Study of sexual hormone changes in prostate cancer patients before and after androgen deprivation therapy Zhonghua Nan Ke Xue 9(3): 191-192; 196
Alvarez Rodríguez, S.; Alonso Gordoa, T.; Burgos Revilla, F.Javier. 2018: Current status of androgen deprivation therapy in hormone-sensitive prostate cancer Archivos Espanoles de Urologia 71(3): 247-257
2015: (P063) Can Some High-Risk Prostate Cancer Patients Be Treated With a Shorter Course of Androgen Deprivation Therapy (ADT)? Oncology 29(4 Suppl. 1)
Pickles, T.; Pollack, A. 2006: The case for dose escalation versus adjuvant androgen deprivation therapy for intermediate risk prostate cancer Canadian Journal of Urology 13(Suppl 2): 68-71
Ziaran, S.; Goncalves, F.M.; Wendl, J.; Trebaticky, B.; Breza, J.S. 2009: Evaluation of bone mass density on patients with prostate cancer prior to the start of androgen deprivation therapy Bratislavske Lekarske Listy 110(9): 559-562
Korneev, I.A. 2012: Practical aspects of use of hormone replacement therapy with testosterone for age-related androgen deficiency in men Urologiia 5: 122-124; 126-127
Raynor, M.C.; Carson, C.C.; Pearson, M.D.; Nix, J.W. 2007: Androgen deficiency in the aging male: a guide to diagnosis and testosterone replacement therapy Canadian Journal of Urology 14(Suppl 1): 63-68
Walecka, W.; Habrat, E. 1991: Changes in cognitive functions after sleep deprivation as a prognostic indicator of drug therapy of endogenous depression Psychiatria Polska 25(3-4): 90-95
Blank, K.R.; Whittington, R.; Arjomandy, B.; Wein, A.J.; Broderick, G.; Staley, J.; Malkowicz, S.B. 1999: Neoadjuvant androgen deprivation prior to transperineal prostate brachytherapy: smaller volumes, less morbidity Cancer Journal From Scientific American 5(6): 370-373
Tiwari, S.; Gupta, S.K.; Mehrotra, M.; Agarwal, G.; Awasthi, P.K.; Godbole, M.M. 2002: Short-term androgen deprivation does not alter CaR and VDR mRNA expression in duodenal mucosa in male rats Indian Journal of Experimental Biology 40(7): 780-784
Sunahara, G.I.; Bellward, G.D. 1986: Testosterone metabolism in rat liver cytosolic androgen binding assays Drug Metabolism and Disposition: the Biological Fate of Chemicals 14(3): 366-369
Tremblay, R.R.; Garrido, M.; Rioux, J.E. 1973: Androgen metabolism. 1. Effect of dexamethasone on the level of testosterone production in hirsutism L'Union Medicale du Canada 102(7): 1476-1479
Wang, C.; Swerdloff, R.S. 2002: Should the nonaromatizable androgen dihydrotestosterone be considered as an alternative to testosterone in the treatment of the andropause? Journal of Clinical Endocrinology and Metabolism 87(4): 1462-1466